Clinical Trial

Study to Evaluate the Efficacy of an Avocado Dietary Supplement

Study acronym: METAVO-ONE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This 16-week, randomized, triple-blinded, placebo-controlled study evaluates the effects of an avocado dietary supplement (Metavo) on healthy weight and blood glucose management in overweight adults. The study includes body measurements, questionnaires, blood tests, and CGM monitoring to assess metabolic outcomes and participant-reported perceptions of well-being.
Trial Details
NCT Number NCT07354308
Lead Sponsor SP Nutraceuticals Inc.
Collaborators: Citruslabs
Conditions Overweight, Metabolic Health, Insulin Resistance
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21